JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis

Janus kinase (JAK) inhibitors are widely used in the treatment of multiple autoimmune and inflammatory diseases. Immunologic and transcriptomic profiling have revealed major alterations on natural killer (NK) cell homeostasis associated with JAK inhibitions, while information on other innate lymphoi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Vian, Laura, Le, Mimi T., Gazaniga, Nathalia, Kieltyka, Jacqueline, Liu, Christine, Pietropaolo, Giuseppe, Dell'Orso, Stefania, Brooks, Stephen R., Furumoto, Yasuko, Thomas, Craig J., O'Shea, John J., Sciumè, Giuseppe, Gadina, Massimo
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930870/
https://ncbi.nlm.nih.gov/pubmed/31921209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02972
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars